VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,383 | -56.1% | 361 | -9.8% | 0.00% | – |
| Q2 2023 | $7,710 | +175.0% | 400 | +100.0% | 0.00% | – |
| Q1 2023 | $2,804 | +70000.0% | 200 | -10.3% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 223 | +11.5% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -50.0% | 200 | -50.0% | 0.00% | – |
| Q1 2022 | $6,000 | -25.0% | 400 | +100.0% | 0.00% | – |
| Q4 2021 | $8,000 | -11.1% | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | -66.7% | 200 | -66.2% | 0.00% | -100.0% |
| Q2 2021 | $27,000 | -18.2% | 591 | -11.3% | 0.00% | 0.0% |
| Q1 2021 | $33,000 | +120.0% | 666 | +9.9% | 0.00% | 0.0% |
| Q4 2020 | $15,000 | -6.2% | 606 | +28.7% | 0.00% | 0.0% |
| Q3 2020 | $16,000 | +128.6% | 471 | +135.5% | 0.00% | 0.0% |
| Q2 2020 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |